![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 44, 34628-34633, November 3, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From INSERM U99, Hopital Henri Mondor, Créteil 94010, France, § INSERM U348, Hopital Lariboisière, Paris
75010, France and ¶ INSERM U466, CHU Rangueil,
Toulouse 31403, France
Proliferation of hepatic myofibroblasts (hMF) is
central for the development of fibrosis during liver injury, and
factors that may limit their growth are potential antifibrotic agents. Sphingosine 1-phosphate (S1P) is a bioactive sphingolipid with growth-regulating properties, either via Edg receptors or through intracellular actions. In this study, we examined the effects of S1P on
the proliferation of human hMF. Human hMF expressed mRNAs for the
S1P receptors Edg1, Edg3, and Edg5. These receptors were functional at
nanomolar concentrations and coupled to pertussis toxin-sensitive and
-insensitive G proteins, as demonstrated in guanosine
5'-3-O-(thio)triphosphate binding assays. S1P potently inhibited hMF growth (IC50 = 1 µM), in a
pertussis toxin-insensitive manner. Analysis of the mechanisms involved
in growth inhibition revealed that S1P rapidly increased prostaglandin
E2 production and in turn cAMP, two growth inhibitory
messengers for hMF; C2-ceramide and sphingosine, which
inhibited hMF proliferation, did not affect cAMP levels. Production of
cAMP by S1P was abolished by NS-398, a selective inhibitor of COX-2.
Also, S1P potently induced COX-2 protein expression. Blocking COX-2 by
NS-398 blunted the antiproliferative effect of S1P. We conclude that
S1P inhibits proliferation of hMF, probably via an intracellular
mechanism, through early COX-2-dependent release of
prostaglandin E2 and cAMP, and delayed COX-2 induction. Our
results shed light on a novel role for S1P as a growth inhibitory mediator and point out its potential involvement in the negative regulation of liver fibrogenesis.
Antiproliferative Properties of Sphingosine 1-Phosphate in
Human Hepatic Myofibroblasts
A CYCLOOXYGENASE-2 MEDIATED PATHWAY*
,
,
*
This work was supported in part by INSERM, the
Université Paris-Val-de-Marne, and by grants from the Association
pour la Recherche sur le Cancer (to S. L.) and the Ligue
Départementale du Val d'Oise de la Recherche Contre le Cancer
(to S. L.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Supported by fellowships from the Ministère de
l'Enseignement et de la Recherche. Both authors contributed equally to
this work.
To whom correspondence should be addressed: Unité INSERM
99, Hôpital Henri Mondor, 94010 Créteil, France. Tel.:
33-1-49 81 35 34; Fax: 33-1-48 98 09 08; E mail:
loterszt@im3.inserm.fr.
This article has been cited by other articles:
![]() |
H. Hasegawa, Y. Yamada, K. Komiyama, M. Hayashi, M. Ishibashi, T. Sunazuka, T. Izuhara, K. Sugahara, K. Tsuruda, M. Masuda, et al. A novel natural compound, a cycloanthranilylproline derivative (Fuligocandin B), sensitizes leukemia cells to apoptosis induced by tumor necrosis factor related apoptosis-inducing ligand (TRAIL) through 15-deoxy-{Delta}12, 14 prostaglandin J2 production Blood, September 1, 2007; 110(5): 1664 - 1674. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Serriere-Lanneau, F. Teixeira-Clerc, L. Li, M. Schippers, W. de Wries, B. Julien, J. Tran-Van-Nhieu, S. Manin, K. Poelstra, J. Chun, et al. The sphingosine 1-phosphate receptor S1P2 triggers hepatic wound healing FASEB J, July 1, 2007; 21(9): 2005 - 2013. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gillibert-Duplantier, V. Neaud, J.-F. Blanc, P. Bioulac-Sage, and J. Rosenbaum Thrombin inhibits migration of human hepatic myofibroblasts Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G128 - G136. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Ki, M. J. Choi, C. H. Lee, and S. G. Kim G{alpha}12 Specifically Regulates COX-2 Induction by Sphingosine 1-Phosphate: ROLE FOR JNK-DEPENDENT UBIQUITINATION AND DEGRADATION OF I{kappa}B{alpha} J. Biol. Chem., January 19, 2007; 282(3): 1938 - 1947. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. H. Zeidan, B. J. Pettus, S. Elojeimy, T. Taha, L. M. Obeid, T. Kawamori, J. S. Norris, and Y. A. Hannun Acid Ceramidase but Not Acid Sphingomyelinase Is Required for Tumor Necrosis Factor-{alpha}-induced PGE2 Production J. Biol. Chem., August 25, 2006; 281(34): 24695 - 24703. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Goparaju, P. S. Jolly, K. R. Watterson, M. Bektas, S. Alvarez, S. Sarkar, L. Mel, I. Ishii, J. Chun, S. Milstien, et al. The S1P2 Receptor Negatively Regulates Platelet-Derived Growth Factor-Induced Motility and Proliferation Mol. Cell. Biol., May 15, 2005; 25(10): 4237 - 4249. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Graupera, S. March, P. Engel, J. Rodes, J. Bosch, and J.-C. Garcia-Pagan Sinusoidal endothelial COX-1-derived prostanoids modulate the hepatic vascular tone of cirrhotic rat livers Am J Physiol Gastrointest Liver Physiol, April 1, 2005; 288(4): G763 - G770. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Damirin, H. Tomura, M. Komachi, M. Tobo, K. Sato, C. Mogi, H. Nochi, K. Tamoto, and F. Okajima Sphingosine 1-Phosphate Receptors Mediate the Lipid-Induced cAMP Accumulation through Cyclooxygenase-2/Prostaglandin I2 Pathway in Human Coronary Artery Smooth Muscle Cells Mol. Pharmacol., April 1, 2005; 67(4): 1177 - 1185. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. I. Kim, E. J. Jo, H.-Y. Lee, M. S. Cha, J. K. Min, C. H. Choi, Y. M. Lee, Y.-A. Choi, S.-H. Baek, S. H. Ryu, et al. Sphingosine 1-Phosphate in Amniotic Fluid Modulates Cyclooxygenase-2 Expression in Human Amnion-derived WISH Cells J. Biol. Chem., August 22, 2003; 278(34): 31731 - 31736. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. PETTUS, J. BIELAWSKI, A. M. PORCELLI, D. L. REAMES, K. R. JOHNSON, J. MORROW, C. E. CHALFANT, L. M. OBEID, and Y. A. HANNUN The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-{alpha} FASEB J, August 1, 2003; 17(11): 1411 - 1421. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Jin, E. Knudsen, L. Wang, Y. Bryceson, B. Damaj, S. Gessani, and A. A. Maghazachi Sphingosine 1-phosphate is a novel inhibitor of T-cell proliferation Blood, June 15, 2003; 101(12): 4909 - 4915. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Davaille, L. Li, A. Mallat, and S. Lotersztajn Sphingosine 1-Phosphate Triggers Both Apoptotic and Survival Signals for Human Hepatic Myofibroblasts J. Biol. Chem., September 27, 2002; 277(40): 37323 - 37330. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Saile, N. Matthes, K. Neubauer, C. Eisenbach, H. El-Armouche, J. Dudas, and G. Ramadori Rat liver myofibroblasts and hepatic stellate cells differ in CD95-mediated apoptosis and response to TNF-alpha Am J Physiol Gastrointest Liver Physiol, August 1, 2002; 283(2): G435 - G444. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gennero, J. Fauvel, M. Nieto, C. Cariven, F. Gaits, F. Briand-Mesange, H. Chap, and J. P. Salles Apoptotic Effect of Sphingosine 1-Phosphate and Increased Sphingosine 1-Phosphate Hydrolysis on Mesangial Cells Cultured at Low Cell Density J. Biol. Chem., April 5, 2002; 277(15): 12724 - 12734. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Y. Sautin, J. M. Crawford, and S. I. Svetlov Enhancement of survival by LPA via Erk1/Erk2 and PI 3-kinase/Akt pathways in a murine hepatocyte cell line Am J Physiol Cell Physiol, December 1, 2001; 281(6): C2010 - C2019. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Li, J. Tao, J. Davaille, C. Feral, A. Mallat, J. Rieusset, H. Vidal, and S. Lotersztajn 15-Deoxy-Delta 12,14-prostaglandin J2 Induces Apoptosis of Human Hepatic Myofibroblasts. A PATHWAY INVOLVING OXIDATIVE STRESS INDEPENDENTLY OF PEROXISOME-PROLIFERATOR-ACTIVATED RECEPTORS J. Biol. Chem., October 5, 2001; 276(41): 38152 - 38158. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |